SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 27 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $87,000 | -3.3% | 306,479 | -7.6% | 0.01% | -33.3% |
| Q4 2021 | $90,000 | +2.3% | 331,543 | +72.4% | 0.01% | +12.5% |
| Q3 2021 | $88,000 | -41.7% | 192,345 | -23.0% | 0.01% | -46.7% |
| Q2 2021 | $151,000 | -52.5% | 249,898 | -46.5% | 0.02% | -34.8% |
| Q1 2021 | $318,000 | +695.0% | 466,704 | +347.1% | 0.02% | +475.0% |
| Q4 2020 | $40,000 | -37.5% | 104,385 | +11.0% | 0.00% | 0.0% |
| Q1 2019 | $64,000 | +814.3% | 94,070 | +669.9% | 0.00% | – |
| Q4 2018 | $7,000 | -92.0% | 12,218 | -63.8% | 0.00% | -100.0% |
| Q3 2018 | $88,000 | – | 33,737 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 903,741 | $497,000 | 0.62% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,750,000 | 0.04% |
| WEDBUSH SECURITIES INC | 97,957 | $54,000 | 0.01% |
| SCOPUS ASSET MANAGEMENT, L.P. | 225,000 | $124,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,000 | $33,000 | 0.00% |
| 683 Capital Management, LLC | 42,858 | $24,000 | 0.00% |
| UBS Group AG | 600 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $1,000 | 0.00% |
| Advisor Group, Inc. | 421 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 316 | $0 | 0.00% |